Archive \ Volume.13 2022 Issue 1

Congestive Heart Failure: Diagnosis and Management in Primary Health Care

 

Ibrahim Abdulrahman Altukhays1*, Salman Hejab Alosaimi1, Meshari Assaf Alotaibi1, Amirh Ayman Zamzami2, Zainab Adel Slais2, Amani Mohammed Al Zainaldeen2, Laila Hassan Hakami3, Badria Fahad Al Saber3, Ahmed Sanad Ibrahim Alrashidi4, Khaled Soud  Alraddadi 4, ‎‏Maitham Ahmed Alfardan5, Mohammed Abdulrahman Alotaibi6

 

1Department of Family Medicine, ‎‏Dwadmi Hospital, Dwadmi, KSA. 2Faculty of Medicine, Medical University of Lodz, Lodz, Poland. 3Faculty of Medicine, King Khaled Hospital, Al-Kharj, KSA. 4MBBS, King Salman Bin Abdulaziz Medical City, Madina, KSA.5Emergency Department, ‎‏Oyun Central Hospital, Al Ahsa, KSA. 6Faculty of Medicine, Shaqra University, Shaqra, KSA.


Abstract

Heart failure disease has been one of the major chronic cardiovascular diseases that cause morbidity, mortality, and hospitalization of all cardiac patients. Heart failure has a significantly increased lifetime risk of development is about 20%. Symptomatic predictions are usually non-specific and hardly can discriminate the occurrence of heart failure from other diseases. It represents a challenging problem because of its economical and medical burden on the health care system. However, the management and presentation of a patient with heart failure remain in the fields of doubt. This review will highlight the importance of diagnosing and managing Congestive heart failure patients for primary health care physicians. This review was collected and classified from eligible published English written documents, articles, clinical trials. This electronic research engine was included: PubMed. This review discussed the diagnosis and management of Congestive heart failure and the details regarding this topic including definitions classifications, were included in this review. The primary care physician approach is often concerned with traditional palliative therapies before worsening the condition and plans to assess different reports regarding heart failure patients throughout their follow-up schedules.

Keywords: Congestive heart failure, Diagnosis, Management, Prognosis, Primary health care


INTRODUCTION

Heart failure disease has been one of the major chronic cardiovascular diseases that cause morbidity, mortality, and hospitalization of all cardiac patients. Heart failure has a significantly increased lifetime risk of development is about 20% [1, 2]. Other studies estimated the overall lifetime risk percent according to gender, where men 33% are higher in developing heart failure than women 28% [3, 4]. Although, congestive heart failure prevalence differs according to the specific studied population. However, the estimated prevalence of heart failure is roughly 1-2% and might increase to >10% among people over 70 of age [4, 5]. Furthermore, there has been a remarkable escalation in the incidence of chronic cardiovascular diseases in recent decades [6, 7].

The final stage of various cardiac issues is usually congestive heart failure. It is represented as a challenging problem because of its economical and medical burden on the health care system. Understanding the pathological and physiological condition of congestive heart failure has improved over the past 20 -30 years, where new modalities for identifying therapies are developed [4, 8].

However, the management and presentation of a patient with heart failure remain in the fields of doubt. In this review, we will highlight the importance of diagnosing and managing Congestive heart failure patients for primary health care physicians.

Low-frequency neuromuscular stimulation is a safe and effective rehabilitation protocol that could partially reverse the abnormal response to exercise in advanced heart failure patients helping in their symptoms and improved activities [9].

In a study, Rano K. sinuraya et al. revealed that the Cost related to CVD in all primary health care centers in Bandung is higher after the implementation of national health insurance [10].

MATERIALS AND METHODS

This review was collected and classified from eligible published English written documents, articles, clinical trials. This electronic research engine was included: PubMed. The keywords “Congestive” ‘Heart’ and ‘Failure’ including words used in Mesh ((((‘Diagnosis’ [Mesh])), ((‘Prognosis’ [Mesh])), ((‘Management’ [Mesh])), ((‘Primary’ [Mesh])) were used in combinations. This review discussed the diagnosis and management of Congestive heart failure and the details regarding this topic including definitions classifications, were included in this review.

Review

Diagnosis

Symptoms and Signs in Clinical Presentation

The progression and prognostic assessment of congestive heart failure depend on the European Society of Cardiology (ESC) 2016 guidelines for diagnosing and treating acute and chronic heart failure and the American college of cardiology\ American heart association (ACC\AHA) [11]. Symptomatic predictions are usually non-specific and hardly can discriminate the occurrence of heart failure from other diseases. However, detection of the early signs of heart failure can be more specific, such as apical impulse displacement and jugular venous pressure elevation (Table 1) [11-13].

Table 1. Symptoms and Signs in Heart failure presentation: [11-13]

Symptoms

Signs

Conventional symptoms

More specific

Breathlessness

Jugular venous pressure elevation

Orthopnea

Hepatojugular reflux

Reduced exercise tolerance

Gallop heart rhythm

Paroxysmal nocturnal dyspnea

Lateral apical impulse displacement

Tiredness, fatigability, more time for exercise recovery

 

Swelling on the ankles

 

Less conventional

Less specific

Wheezing

Weight gain

Bloated feeling

Sudden weight loss

Nocturnal coughing

Tissue wasting

Loss of appetite

Cardiac murmur

Confusion

Peripheral oedema (Ankle, sacral, scrotal)

Depression

Pulmonary crepitations

Palpitations

Dullness to percussion and reduced air entry

Dizziness

Tachycardia

Syncope

Cheyne Stokes respiration

Bendopnea

Hepatomegaly

 

Tachypnoea and Irregular pulse

 

Ascites

 

Cold extremities

 

Oliguria

 

Narrow pulse pressure

 

Risk Factors and Prognosis

In general, heart failure outcome is associated with many significant dependents and independent risk factors. Ethnicity is one of the major risk factors that affect the outcome of the diseases. The predictions of increased risk of deaths in Asian patients with heart failure differ from the European ones [14-16]. Gender differences have often a greater impact impairing the quality of life in patients. In several studies, the overall lifetime risk percent according to gender were men 33% are higher in developing heart failure than women 28% [3, 4].  However, other studies introduced women to have a stronger probability to be affected by congestive heart failure than most men. Moreover, women have a greater probability of developing typical heart failure with preserved ejection fraction than men [17, 18]. Compared to men women have different physiological features that are considered a strong risk factor for heart failure development (Table 2) [19].

Table 2. Women Characteristic physiological and anatomical features in comparison to men: [19]

Physiological and Anatomical features

Women compared to men

Mass at the left ventricle

Lower

Apoptosis and cell turnovers

Lower

Blood pressure

Lower

Resting heart rate

Higher

Contractility

Greater

Catecholamine-mediated vasoconstriction

Less

Coronary vessel caliber

Smaller

 

Unplanned hospitalization of patients with heart failure, nominates marks of mortality, and recurrent hospitalization [16, 20, 21]. Cardiovascular and non-cardiovascular comorbid diseases play a sensitive role in maintaining the prognostic statements of congestive heart failure progression. These comorbidities highly impact the diagnosis and management of heart failure. Diabetes, anemia, and metabolic iron deficiency (Table 3) are often observed in congestive heart failure patients and are acknowledged to complication the prognostic assessment of heart failure.

 

Table 3. Heart failure impact on Anemia and iron deficiency [22]

Anemia

Iron deficiency

Renal impairment

Iron absorption impairment.

Chronic inflammatory disorder

Malnutrition and iron intake reduction.

Dysfunction of the Bone Marrow

Blood loss from the Gastrointestinal area.

Hemodilution

Sequestration due to impaired iron transition leading to Chronic inflammation.

Iron deficiency anemia

 

 

Diabetes mellitus risk of presence might not worsen the survival rate after all, but it does interplay a significant role with the etiology that increases the risk of deaths in patients with heart failure. This depends on the duration, other comorbidities, and damaged organs (Table 4) [22, 23]. Diabetes type 2 is found to have strong mortality risks in heart failure patients compared with cardiac patients without diabetes [22, 24].

Table 4. Classes of cardiovascular risk in diabetic patients [22, 23]

Cardiovascular risk degree

Condition

Very high

  • Existing cardiovascular disease and diabetes accompanied by end-organ damage.
  • Cardiovascular risk for more than 3 years
  • Diabetes for more than 20 years

High

  • Diabetes for more than 10 years not associated with organ damage, but with cardiovascular risks.

Moderate

  • Type 1 diabetes in patients more than 35 years of age of a 10 years duration with no cardiovascular risks.
  • Type 2 diabetes in patients more than 50 years of age of a 10years duration with no cardiovascular risks.

Practical Management of Congestive Heart Failure in Primary Healthcare

In the practical management of congestive heart failure, patients might experience various levels of intense symptoms and signs underlying this condition. The primary care physician approach is often concerned with traditional palliative therapies before worsening the condition and plans to assess different reports regarding heart failure patients throughout their follow-up schedules. If the role of palliative care is ineffectual then a referral should be noted [25]. The (Table 5) below presents a brief idea about the practical management of heart failure with preserved ejection fraction [26].

Table 5. Palliative management in heart failure with preserved ejection fraction [26]

Lowest effective dose of diuretics to monitor volume overload

Moderate restriction of Sodium diet

Patient education on weight changes and how to maintain a perfect weight

Comprehensive counseling about follow up and management especially for newly hospitalized patients

Monitoring blood pressure, blood sugar, and other comorbidities

Intensive heart rate control and sinus rhythm maintenance

Treat myocardial ischemia

Sleep assessment for patients with suspected breathing disorders during the night or daytime excessive sleepiness

Follow up moderate regular physical activity

 

CONCLUSION

Heart failure has a significantly increased lifetime risk of development is about 20%. The final stage of various cardiac issues is usually congestive heart failure. It is represented as a challenging problem because of its economical and medical burden on the health care system. Ethnicity and gender differences had often a greater impact impairing the quality of life in patients. However, the progression and prognostic assessment of congestive heart failure depend on the European Society of Cardiology (ESC) 2016 guidelines for diagnosing and treating acute and chronic heart failure and the American college of cardiology\ American heart association (ACC\AHA. In the practical management of congestive heart failure, patients might experience various levels of intense symptoms and signs underlying this condition. The primary care physician approach is often concerned with traditional palliative therapies before worsening the condition and plans to assess different reports regarding heart failure patients throughout their follow-up schedules. If the role of palliative care is ineffectual then a referral should be noted.

 

ACKNOWLEDGMENTS: None

CONFLICT OF INTEREST: None

FINANCIAL SUPPORT: None

ETHICS STATEMENT: None

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.